| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |